pharmacodynamic biomarkers for biosimilar development and approval: day 2
Published 3 years ago • 436 plays • Length 3:42:11Download video MP4
Download video MP3
Similar videos
-
3:35:15
pharmacodynamic biomarkers for biosimilar development and approval: day 1
-
9:50
the role of pharmacodynamic biomarkers in biosimilar drug development
-
14:19
regulatory pathway for biosimilars
-
5:47
how biomarkers can improve the drug development process
-
4:12
the basics of biosimilars
-
4:20
the biosimilar development process
-
18:36
development and validation of cerebrospinal fluid & blood biomarkers for neurodegenerative diseases
-
25:07
office of clinical pharmacology (ocp): biosimilars - bioanalysis 2020
-
1:36
interchangeable biosimilars
-
2:05
what are biomarkers and why are they important?
-
2:01
mononuclear cell pellets and plasma: biomarker analysis | protocol preview
-
46:33
biomarkers of drug effects of dr. robert schuck
-
1:32
the regulation of biosimilars
-
1:35
polpharma biologics - biosimilar novel pipeline
-
0:56
using biomarkers to determine medicines’ effectiveness
-
2:01
bmp antagonist grem2 to differentiate cardiomyocytes from stem cells | protocol preview
-
1:42
advantages of using biosimilars